probability
93 %  
93 %  
Last valuation: Jan 26, 2024
Last valuation: Jan 26, 2024
A. Vermeeren zum Atlético Madrid?
Jan 23, 2024 - 9:59 PM hours
FabrizioRomano
More details on Arthur Vermeeren and Atléti deal.
Understand club agreed on €22m fixed fee plus add-ons.
Antwerp will also have sell-on clause.
He won’t travel tomorrow, may be Thursday.
Contract still being discussed with the player before ‘here we go’.
Den Spieler zieht es also nach Madrid.
More details on Arthur Vermeeren and Atléti deal.
Understand club agreed on €22m fixed fee plus add-ons.
Antwerp will also have sell-on clause.
He won’t travel tomorrow, may be Thursday.
Contract still being discussed with the player before ‘here we go’.
Show results 1-2 of 2.
Jan 24, 2024 - 10:16 AM hours
Source: x.com
Fabrizio Romano
@FabrizioRomano
Atlético Madrid are preparing formal documents for Arthur Vermeeren deal after the agreement with Antwerp on €22m fee plus add-ons.
Atléti will also speak again to Arthur and his camp today in order to complete personal terms agreement and get the deal sealed.
@FabrizioRomano
Atlético Madrid are preparing formal documents for Arthur Vermeeren deal after the agreement with Antwerp on €22m fee plus add-ons.
Atléti will also speak again to Arthur and his camp today in order to complete personal terms agreement and get the deal sealed.
Jan 26, 2024 - 12:39 AM hours
Source: x.com
Fabrizio Romano
@FabrizioRomano
Atlético Madrid have booked medical tests for Arthur Vermeeren on Friday morning.
Contract to be signed overnight, here we go coming soon.
Der Spieler wird Freitag früh den Medizincheck absolvieren
@FabrizioRomano
Atlético Madrid have booked medical tests for Arthur Vermeeren on Friday morning.
Contract to be signed overnight, here we go coming soon.
Do you really want to delete the complete thread?
Do you really want to delete this post?
Bookmark
Subscribed threads
Use the thread search if you want to move this thread to a different thread. Click on create thread if you want to turn this post into a stand-alone thread.